Advance in the anti-tumor mechanism of triptolide.
- Author:
Yongwei LUO
1
;
Chang SHI
;
Mingyang LIAO
Author Information
1. National Beijing Center for Drug Safety Evaluation and Research, Beijing Institute of Pharmacology and Toxicology, Academy of Military Medical Science, Beijing 100850, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Antineoplastic Agents;
therapeutic use;
Apoptosis;
drug effects;
Cell Cycle;
drug effects;
Diterpenes;
therapeutic use;
Drugs, Chinese Herbal;
therapeutic use;
Epoxy Compounds;
therapeutic use;
Humans;
Neoplasms;
drug therapy;
physiopathology;
Phenanthrenes;
therapeutic use;
Tripterygium;
chemistry
- From:
China Journal of Chinese Materia Medica
2009;34(16):2024-2026
- CountryChina
- Language:Chinese
-
Abstract:
Triptolide, an epoxidated diterpene lactone compound separated from a traditional Chinese medicine, Tripterygium wilfordiiHook. f (TWHF), is responsible for the anti-tumor activity of TWHF with broad spectrum and high performance. The antitumor mechanism of triptolide locates in many fields, such as inducing apoptosis of tumor cell, interfering in the cell cycle, and suppressing angiogeneis. The advance in the anti-tumor mechanism of triptolide is described in the following review.
